Læknaneminn


Læknaneminn - 01.10.1996, Qupperneq 99

Læknaneminn - 01.10.1996, Qupperneq 99
Rannsóknarverkefni 4, árs læknanema, útdrættir Semliki forest virus transfection as a means to generate antisense RNA in living cells Anna Marprét Halldórsdóttir1. Anke Huckriede2, Astrid Heikema2 'LHI, "Laboratory of Physiological Chemistry, University of Groningen. Introduction: Antisense RNA molecules complementary to mRNAs can inhibit (or reduce) expression of cellular genes in a specific manner. They have been used extrensively to ex- perimentally control expression of different proteins in eukaryotic cells and offer a model for future specific gene therapy. Currently used approaches in applying antisense RNAs to cells have many drawbacks, including inefficiency and being only suitable for in vitro experiments. The aim of this project is to explore whether Semliki for- est virus mediated transfection is suitable for the generation of antisens RNA in living cells. The SVF transfection system is an efficient system for the transient expression of recomb- inant proteins. It involves cloning of the gene of interest into a plasmid (pSFVs) containing a DNA copy of a part of the SFV RNA genome. After transcription of plasmids, contrans- fection of recombinant RNA and helper RNA, encoding the structure virus proteins, results in production of recombinant SFV particles. First the effect of “empty” SFV particles (encoding viral genes only) on cellular protein synthesis in general has to be determined. If this proves to be extensively impaired, SFV will not be useful as an antisense RNA “vector”, as the aim is to inhibit production of only one specific prot- ein, with as little effect on the general cell function as possible. Materials and methods: First the “empty” SFV particles had to be produced: Linearized and purified pSFVj and pHelperl plasmids were transcribed in vitro to produce complementary RNAs, which were checked on gel and ther- eafter coelectroporated into Baby Hamster Kidney (BHK21) cells. The cells were grown for 26 hours and cell medium removed. To obtain purified viral particles for character- ization, part of the medium was ultracentrifugated on a sucrose gradient. Viral proteins were separated using SDS- PAGE and detected on Western blots using antibodies spe- cific to the viral structural protein E1. BHK 21 cells were in- fected with the “empty” SFV particles by applying 500 and lOOOpl of medium containing the particles to cell cultures. Six hours after infection effects on protein synthesis were det- ermined by a pulse chase experiment. Noninfected cells and cells infected with SFV-DHFR recombinant served as con- trols. After incubation with radioactive 35S-Met for 20 min, cells were washed, lysed and radiactivity determined by scin- tillation counting and fluorography. Results: Production of “empty” SFV particles was success- ful. Western blots showed clear bands of the E1 protein that were on the same height as those of purified original SFV. Comparison with another recombinant SFV stock showed that the amount of virus particles obtained was adequate for infection purposes. Data from the pulse-chase are not yet complete. Scintillation counts gave bizarre results, the prot- ein synthesis being increased in cells infected with 1 OOOpl but lowered in cells infected with 500pl of empty virus particles. Validity of data is uncertain. Preliminary fluorography showed no obvious change in protein production in cells in- fected with 1000 or 500 U1 of empty SFV particles, com- pared to uninfected cells. Discussion: Available results are too preliminary to draw definite conclusions about the effects of “empty” SFV part- icles on host cell protein synthesis, however the results of the initial experiment are promising in the way that protein synt- hesis seems not to be inhibited. More pulse-chase ex- periments should though be conducted, preferably using several time-points postinfection rather than one. If this empty particle proves to have no significant effects on cell protein production, SFV will be tried out as an antisense vector. The other outcome - definite inhibition of protein synthesis - would still be interesting, as it suggests that synt- hesis of virus structural proteins is not the only reason for decreased protein production in SFV infected cells. Tap á arfblendni á litningi 7q í brjóstakrabba- meini; samband við klínískar breytur Árni Kjalar Kristiánsson Guðný Eiríksdóttir 2, Sigurður Ingvarsson 2. 'LHÍ, "Frumulíffræðideild Lsp. Inngangur: Brjóstakrabbamein er algengasta krabbamein- ið meðal íslenskra kvenna og veldur flestum dauðsföllum sem rekja má til krabbameina. Breytingar í erfðamengi brjóstakrabbameinsfruma eru algengar og taldar eiga þátt í myndun og þróun krabbbameins. Þessar breytingar má flokka í þrennt. I fyrsta lági punktstökkbreytingar í æxlisgen- um og æxlisbæligenum sém eru fremur sjaldgæfar í brjósta- krabbameinum. I öðru lagi magnanir á æxlisgenum og loks úrfellingar á litnin^asvæðum sem bera æxlisbæligen, en það eru algengustu breytingarnar í brjóstakrabbameinum. Afurð- ir æxlisbæligens gegna vaxtarhindrandi hlutverki. Til að æxlis- bæligen verði óstarfhæft þurfa yfirleitt báðar samsætur (allele) þess að vera óvirkar. Önnur samsætan skemmist oft með stökkbreytingu en hin vegna úrfellingar á Iitningabút sem hefur að geyma samsætuna, þannig að einstaldingur sem var arfblendinn fyrir samsætuna er orðinn arfhreinn, þ.e. hefur tapað arfblendni. Stökkbreytingin á fyrri samsætunni er í raun víkjandi breyting og getur erfst milli kynslóða sem kím- línubreyting og gert viðkomandi einstakling útsettari fyrir krabbamein síðar á ævinni. Litningarannsóknir og sameindaerfðafræðirannsóknir hafa sýnt úrfellingar á 7q í ýmsum krabbameinum, þ.á.m. brjóstakrabbameinum. LÆKNANEMINN 89 2. tbl. 1996, 49. árg.
Qupperneq 1
Qupperneq 2
Qupperneq 3
Qupperneq 4
Qupperneq 5
Qupperneq 6
Qupperneq 7
Qupperneq 8
Qupperneq 9
Qupperneq 10
Qupperneq 11
Qupperneq 12
Qupperneq 13
Qupperneq 14
Qupperneq 15
Qupperneq 16
Qupperneq 17
Qupperneq 18
Qupperneq 19
Qupperneq 20
Qupperneq 21
Qupperneq 22
Qupperneq 23
Qupperneq 24
Qupperneq 25
Qupperneq 26
Qupperneq 27
Qupperneq 28
Qupperneq 29
Qupperneq 30
Qupperneq 31
Qupperneq 32
Qupperneq 33
Qupperneq 34
Qupperneq 35
Qupperneq 36
Qupperneq 37
Qupperneq 38
Qupperneq 39
Qupperneq 40
Qupperneq 41
Qupperneq 42
Qupperneq 43
Qupperneq 44
Qupperneq 45
Qupperneq 46
Qupperneq 47
Qupperneq 48
Qupperneq 49
Qupperneq 50
Qupperneq 51
Qupperneq 52
Qupperneq 53
Qupperneq 54
Qupperneq 55
Qupperneq 56
Qupperneq 57
Qupperneq 58
Qupperneq 59
Qupperneq 60
Qupperneq 61
Qupperneq 62
Qupperneq 63
Qupperneq 64
Qupperneq 65
Qupperneq 66
Qupperneq 67
Qupperneq 68
Qupperneq 69
Qupperneq 70
Qupperneq 71
Qupperneq 72
Qupperneq 73
Qupperneq 74
Qupperneq 75
Qupperneq 76
Qupperneq 77
Qupperneq 78
Qupperneq 79
Qupperneq 80
Qupperneq 81
Qupperneq 82
Qupperneq 83
Qupperneq 84
Qupperneq 85
Qupperneq 86
Qupperneq 87
Qupperneq 88
Qupperneq 89
Qupperneq 90
Qupperneq 91
Qupperneq 92
Qupperneq 93
Qupperneq 94
Qupperneq 95
Qupperneq 96
Qupperneq 97
Qupperneq 98
Qupperneq 99
Qupperneq 100
Qupperneq 101
Qupperneq 102
Qupperneq 103
Qupperneq 104
Qupperneq 105
Qupperneq 106
Qupperneq 107
Qupperneq 108
Qupperneq 109
Qupperneq 110
Qupperneq 111
Qupperneq 112
Qupperneq 113
Qupperneq 114
Qupperneq 115
Qupperneq 116
Qupperneq 117
Qupperneq 118
Qupperneq 119
Qupperneq 120
Qupperneq 121
Qupperneq 122
Qupperneq 123
Qupperneq 124
Qupperneq 125
Qupperneq 126
Qupperneq 127
Qupperneq 128
Qupperneq 129
Qupperneq 130
Qupperneq 131
Qupperneq 132

x

Læknaneminn

Direct Links

Hvis du vil linke til denne avis/magasin, skal du bruge disse links:

Link til denne avis/magasin: Læknaneminn
https://timarit.is/publication/1885

Link til dette eksemplar:

Link til denne side:

Link til denne artikel:

Venligst ikke link direkte til billeder eller PDfs på Timarit.is, da sådanne webadresser kan ændres uden advarsel. Brug venligst de angivne webadresser for at linke til sitet.